4D Molecular Therapeutics Inc (FDMT)
25.31
-0.33
(-1.29%)
USD |
NASDAQ |
May 17, 16:00
25.31
0.00 (0.00%)
After-Hours: 20:00
4D Molecular Therapeutics Market Cap: 1.309B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.326B |
| May 15, 2024 | 1.323B |
| May 14, 2024 | 1.331B |
| May 13, 2024 | 1.322B |
| May 10, 2024 | 1.329B |
| May 09, 2024 | 1.326B |
| May 08, 2024 | 1.361B |
| May 07, 2024 | 1.386B |
| May 06, 2024 | 1.384B |
| May 03, 2024 | 1.364B |
| May 02, 2024 | 1.350B |
| May 01, 2024 | 1.299B |
| April 30, 2024 | 1.224B |
| April 29, 2024 | 1.241B |
| April 26, 2024 | 1.189B |
| April 25, 2024 | 1.204B |
| April 24, 2024 | 1.241B |
| April 23, 2024 | 1.269B |
| April 22, 2024 | 1.350B |
| April 19, 2024 | 1.292B |
| April 18, 2024 | 1.268B |
| April 17, 2024 | 1.294B |
| April 16, 2024 | 1.368B |
| April 15, 2024 | 1.343B |
| April 12, 2024 | 1.348B |
| Date | Value |
|---|---|
| April 11, 2024 | 1.417B |
| April 10, 2024 | 1.378B |
| April 09, 2024 | 1.386B |
| April 08, 2024 | 1.471B |
| April 05, 2024 | 1.463B |
| April 04, 2024 | 1.414B |
| April 03, 2024 | 1.428B |
| April 02, 2024 | 1.431B |
| April 01, 2024 | 1.535B |
| March 28, 2024 | 1.586B |
| March 27, 2024 | 1.786B |
| March 26, 2024 | 1.695B |
| March 25, 2024 | 1.673B |
| March 22, 2024 | 1.673B |
| March 21, 2024 | 1.682B |
| March 20, 2024 | 1.668B |
| March 19, 2024 | 1.594B |
| March 18, 2024 | 1.545B |
| March 15, 2024 | 1.569B |
| March 14, 2024 | 1.462B |
| March 13, 2024 | 1.463B |
| March 12, 2024 | 1.420B |
| March 11, 2024 | 1.421B |
| March 08, 2024 | 1.472B |
| March 07, 2024 | 1.469B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
183.46M
Minimum
Jun 16 2022
1.786B
Maximum
Mar 27 2024
718.92M
Average
698.64M
Median
Apr 25 2023
Market Cap Benchmarks
| Ionis Pharmaceuticals Inc | 5.446B |
| NovaBay Pharmaceuticals Inc | 4.494M |
| Palatin Technologies Inc | 32.52M |
| iBio Inc | 6.899M |
| Theriva Biologics Inc | 6.634M |
Market Cap Related Metrics
| PS Ratio | 53.44 |
| Price to Book Value | 2.179 |
| Price | 25.31 |
| Earnings Yield | -9.64% |